(-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of ITGAV mRNA CTD PMID:16084531 (R)-adrenaline increases expression EXP 6480464 Epinephrine results in increased expression of ITGAV mRNA CTD PMID:12729923 (S)-nicotine increases expression ISO RGD:1617623 6480464 Nicotine results in increased expression of ITGAV mRNA CTD PMID:17997037 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:1617623 6480464 Dinitrochlorobenzene affects the expression of ITGAV mRNA CTD PMID:22302311 1-naphthyl isothiocyanate increases expression ISO RGD:1310613 6480464 1-Naphthylisothiocyanate results in increased expression of ITGAV mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression ISO RGD:1310613 6480464 Ethinyl Estradiol results in increased expression of ITGAV mRNA CTD PMID:29097150 17beta-estradiol increases expression ISO RGD:1617623 6480464 Estradiol results in increased expression of ITGAV mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ITGAV mRNA CTD PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of ITGAV mRNA CTD PMID:29581250 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1310613 6480464 2 more ... CTD PMID:32109520 2,6-dinitrotoluene affects expression ISO RGD:1310613 6480464 2, 6-dinitrotoluene affects the expression of ITGAV mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1617623 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ITGAV mRNA CTD PMID:26251327 4-hydroxyphenyl retinamide increases expression ISO RGD:1617623 6480464 Fenretinide results in increased expression of ITGAV mRNA CTD PMID:28973697 4-vinylcyclohexene dioxide affects expression ISO RGD:1617623 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of ITGAV mRNA CTD PMID:20829426 5-fluorouracil affects response to substance EXP 6480464 ITGAV protein affects the susceptibility to Fluorouracil CTD PMID:16217747 acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ITGAV mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ITGAV mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:1310613 6480464 Acrylamide results in decreased expression of ITGAV mRNA CTD PMID:22197712 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of ITGAV protein CTD PMID:20106945 aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of ITGAV gene CTD PMID:27153756 , PMID:28458013 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of ITGAV mRNA CTD PMID:31655124 all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin results in increased cleavage of [ITGAV protein binds to ITGB1 protein], Tretinoin results in increased expression of [ITGAV protein binds to ITGB1 protein] CTD PMID:11369141 , PMID:11718225 all-trans-retinoic acid multiple interactions ISO RGD:1617623 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ITGAV mRNA CTD PMID:30951980 alpha-hexylcinnamaldehyde affects expression ISO RGD:1617623 6480464 hexyl cinnamic aldehyde affects the expression of ITGAV mRNA CTD PMID:22302311 alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ITGAV mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ITGAV mRNA CTD PMID:32699268 Arg-Gly-Asp multiple interactions EXP 6480464 arginyl-glycyl-aspartic acid inhibits the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]] CTD PMID:15213856 arsenite(3-) decreases expression ISO RGD:1617623 6480464 arsenite results in decreased expression of ITGAV mRNA CTD PMID:18191166 arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ITGAV mRNA CTD PMID:25913414 benzo[a]pyrene multiple interactions EXP 6480464 Benzoapyrene inhibits the reaction [FGF2 protein results in increased expression of [ITGAV protein binds to ITGB3 protein]], Benzoapyrene inhibits the reaction [FGF2 protein results in increased expression of ITGAV protein] CTD PMID:20876236 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of ITGAV promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of ITGAV mRNA CTD PMID:26238291 , PMID:32234424 bisphenol A increases expression ISO RGD:1617623 6480464 bisphenol A results in increased expression of ITGAV mRNA CTD PMID:26063408 bisphenol A increases expression ISO RGD:1310613 6480464 bisphenol A results in increased expression of ITGAV mRNA CTD PMID:29097150 bisphenol F multiple interactions ISO RGD:1617623 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ITGAV mRNA CTD PMID:30951980 bortezomib multiple interactions EXP 6480464 [arsenic trioxide co-treated with Bortezomib] results in decreased expression of ITGAV mRNA CTD PMID:25913414 bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of ITGAV mRNA CTD PMID:20471514 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ITGAV protein CTD PMID:24527689 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of ITGAV mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1617623 6480464 Nanotubes more ... CTD PMID:25554681 chloropicrin decreases expression EXP 6480464 chloropicrin results in decreased expression of ITGAV mRNA CTD PMID:26352163 , PMID:28476498 choline multiple interactions ISO RGD:1617623 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ITGAV, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ITGAV gene CTD PMID:20938992 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ITGAV mRNA more ... CTD PMID:25594011 , PMID:27392435 copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of ITGAV mRNA more ... CTD PMID:24690739 more ... copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of ITGAV mRNA more ... CTD PMID:24690739 more ... copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of ITGAV mRNA CTD PMID:19549813 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ITGAV mRNA CTD PMID:20106945 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ITGAV mRNA CTD PMID:25562108 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of ITGAV mRNA CTD PMID:31655124 dabrafenib multiple interactions EXP 6480464 dabrafenib inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [ITGAV protein binds to ITGB5 protein]] CTD PMID:29042256 diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of ITGAV protein CTD PMID:28741790 diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of ITGAV mRNA CTD PMID:25913414 dibutyl phthalate increases expression ISO RGD:1617623 6480464 Dibutyl Phthalate results in increased expression of ITGAV mRNA CTD PMID:21266533 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in increased expression of ITGAV mRNA CTD PMID:24690739 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ITGAV mRNA CTD PMID:27188386 endosulfan decreases expression ISO RGD:1310613 6480464 Endosulfan results in decreased expression of ITGAV mRNA CTD PMID:29391264 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ITGAV mRNA CTD PMID:27188386 entinostat decreases expression EXP 6480464 entinostat results in decreased expression of ITGAV mRNA CTD PMID:26272509 ethanol decreases expression ISO RGD:1617623 6480464 Ethanol results in decreased expression of ITGAV mRNA CTD PMID:29018328 ethanol affects expression ISO RGD:1617623 6480464 Ethanol affects the expression of ITGAV mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of ITGAV mRNA CTD PMID:23649840 fenamidone increases expression ISO RGD:1617623 6480464 fenamidone results in increased expression of ITGAV mRNA CTD PMID:27029645 fenhexamid increases expression EXP 6480464 N-2, 3-dichloro-4-hydroxyphenyl-1-methylcyclohexanecarboxamide results in increased expression of ITGAV mRNA CTD PMID:25461557 folic acid multiple interactions ISO RGD:1617623 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ITGAV, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ITGAV gene CTD PMID:20938992 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of ITGAV mRNA CTD PMID:23649840 gefitinib multiple interactions ISO RGD:1617623 6480464 gefitinib inhibits the reaction [TNF protein results in increased expression of ITGAV mRNA] CTD PMID:15841081 gemcitabine multiple interactions EXP 6480464 [ITGB6 co-treated with ITGAV] affects the susceptibility to gemcitabine CTD PMID:20150628 genistein decreases expression EXP 6480464 Genistein results in decreased expression of ITGAV protein CTD PMID:20884965 genistein multiple interactions EXP 6480464 ESR2 promotes the reaction [Genistein results in decreased expression of ITGAV protein] CTD PMID:20884965 glucose decreases expression EXP 6480464 Glucose results in decreased expression of ITGAV mRNA CTD PMID:31655124 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of ITGAV mRNA CTD PMID:31295307 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ITGAV mRNA CTD PMID:12419474 irinotecan decreases expression EXP 6480464 Irinotecan metabolite results in decreased expression of ITGAV mRNA, Irinotecan results in decreased expression of ITGAV mRNA CTD PMID:15956246 isotretinoin increases expression EXP 6480464 Isotretinoin results in increased expression of ITGAV mRNA CTD PMID:20436886 L-methionine multiple interactions ISO RGD:1617623 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ITGAV, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ITGAV gene CTD PMID:20938992 lead(0) affects expression EXP 6480464 Lead affects the expression of ITGAV mRNA CTD PMID:28903495 lead(2+) affects expression EXP 6480464 Lead affects the expression of ITGAV mRNA CTD PMID:28903495 lipopolysaccharide increases secretion EXP 6480464 Lipopolysaccharides results in increased secretion of ITGAV protein alternative form CTD PMID:27887929 lipopolysaccharide multiple interactions EXP 6480464 Triterpenes inhibits the reaction [Lipopolysaccharides results in increased secretion of ITGAV protein alternative form] CTD PMID:27887929 LY294002 multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]] CTD PMID:15213856 manganese(II) chloride multiple interactions EXP 6480464 2-4-morpholinyl-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]] more ... CTD PMID:15213856 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of ITGAV mRNA CTD PMID:23649840 methyl salicylate affects expression ISO RGD:1617623 6480464 methyl salicylate affects the expression of ITGAV mRNA CTD PMID:22302311 monosodium L-glutamate decreases expression ISO RGD:1617623 6480464 Sodium Glutamate results in decreased expression of ITGAV mRNA CTD PMID:22078008 N-acetyl-L-cysteine decreases expression EXP 6480464 Acetylcysteine results in decreased expression of ITGAV mRNA CTD PMID:16084531 niclosamide multiple interactions EXP 6480464 Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ITGAV mRNA] CTD PMID:26792726 nicotine increases expression ISO RGD:1617623 6480464 Nicotine results in increased expression of ITGAV mRNA CTD PMID:17997037 nitrofen increases expression ISO RGD:1310613 6480464 nitrofen results in increased expression of ITGAV protein CTD PMID:15119844 nonanoic acid affects expression ISO RGD:1617623 6480464 pelargonic acid affects the expression of ITGAV mRNA CTD PMID:22302311 ouabain decreases expression EXP 6480464 Ouabain results in decreased expression of ITGAV mRNA CTD PMID:28795476 oxaliplatin multiple interactions ISO RGD:1310613 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ITGAV mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ITGAV mRNA more ... CTD PMID:32699268 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ITGAV mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of ITGAV mRNA CTD PMID:27153767 phthalaldehyde affects expression ISO RGD:1617623 6480464 o-Phthalaldehyde affects the expression of ITGAV mRNA CTD PMID:22302311 pioglitazone multiple interactions EXP 6480464 pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA] CTD PMID:20847119 pirinixic acid multiple interactions ISO RGD:1617623 6480464 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of ITGAV mRNA] CTD PMID:17950772 pirinixic acid decreases expression ISO RGD:1617623 6480464 pirinixic acid results in decreased expression of ITGAV mRNA CTD PMID:17950772 potassium chromate decreases expression EXP 6480464 potassium chromateVI results in decreased expression of ITGAV mRNA CTD PMID:22714537 Ptaquiloside decreases expression ISO RGD:1617623 6480464 ptaquiloside results in decreased expression of ITGAV mRNA CTD PMID:23274088 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ITGAV mRNA CTD PMID:21632981 quercetin multiple interactions ISO RGD:1310613 6480464 Quercetin results in decreased expression of [ITGB3 protein binds to ITGAV protein] CTD PMID:28431985 rebaudioside A decreases expression EXP 6480464 rebaudioside A results in decreased expression of ITGAV mRNA CTD PMID:31655124 resveratrol multiple interactions EXP 6480464 resveratrol promotes the reaction [[ITGAV protein binds to ITGB3 protein] which affects the localization of FYN protein] more ... CTD PMID:21467134 rimonabant multiple interactions ISO RGD:1617623 6480464 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ITGAV mRNA] CTD PMID:19030233 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of ITGAV mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:1617623 6480464 Silver results in decreased expression of ITGAV mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1617623 6480464 Silver results in decreased expression of ITGAV mRNA CTD PMID:27131904 sirolimus decreases expression ISO RGD:1617623 6480464 Sirolimus results in decreased expression of ITGAV mRNA, Sirolimus results in decreased expression of ITGAV protein CTD PMID:19922502 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ITGAV mRNA CTD PMID:12016162 Soman increases expression ISO RGD:1310613 6480464 Soman results in increased expression of ITGAV mRNA CTD PMID:19281266 steviol decreases expression EXP 6480464 steviol results in decreased expression of ITGAV mRNA CTD PMID:31655124 stevioside decreases expression EXP 6480464 stevioside results in decreased expression of ITGAV mRNA CTD PMID:31655124 streptozocin affects expression ISO RGD:1617623 6480464 Streptozocin affects the expression of ITGAV mRNA CTD PMID:26073000 succimer multiple interactions ISO RGD:1617623 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAV mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAV mRNA CTD PMID:21641980 , PMID:26378955 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of ITGAV mRNA CTD PMID:31533062 tert-butyl hydroperoxide multiple interactions EXP 6480464 [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ITGAV mRNA more ... CTD PMID:20847119 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of ITGAV mRNA CTD PMID:20847119 testosterone enanthate affects expression EXP 6480464 testosterone enanthate affects the expression of ITGAV mRNA CTD PMID:17440010 tetrachloromethane affects expression ISO RGD:1617623 6480464 Carbon Tetrachloride affects the expression of ITGAV mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1617623 6480464 Carbon Tetrachloride results in increased expression of ITGAV mRNA CTD PMID:31919559 thioacetamide increases expression ISO RGD:1310613 6480464 Thioacetamide results in increased expression of ITGAV mRNA CTD PMID:23411599 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of ITGAV mRNA CTD PMID:24023007 topotecan multiple interactions ISO RGD:1310613 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ITGAV mRNA CTD PMID:25729387 trimellitic anhydride affects expression ISO RGD:1617623 6480464 trimellitic anhydride affects the expression of ITGAV mRNA CTD PMID:22302311 troglitazone decreases expression ISO RGD:1617623 6480464 troglitazone results in decreased expression of ITGAV mRNA CTD PMID:28973697 troglitazone multiple interactions EXP 6480464 troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA] CTD PMID:20847119 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of ITGAV gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ITGAV mRNA CTD PMID:23179753 , PMID:28001369 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [manganese chloride affects the localization of and affects the activity of [ITGB3 protein binds to ITGAV protein]] CTD PMID:15213856 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of ITGAV mRNA CTD PMID:19071009 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of ITGAV mRNA CTD PMID:19071009